Clinical Trial Update: Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy [Phase 2]

View source ↗

Summary

A Phase 2 prospective study assessing whether Diffuse Noxious Inhibitory Controls influence the efficacy of milnacipran in fibromyalgia; current trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Fibromylagia | Phase 2 | Status: UNKNOWN